Introduction {#Sec1}
============

The presence of intracellular cardiac troponin subunits T and I (cTnT and cTnI) in the blood is a sensitive and specific indicator for myocardial injury (Thygesen et al. [@CR31]; Wu [@CR34]), whilst elevated cTn levels play a central role in the diagnosis of acute myocardial infarction (AMI) (Kragelj et al. [@CR17]; Thygesen et al. [@CR31]). Previous studies have also reported release of circulating cTnT/cTnI concentrations after prolonged exercise, with cTn levels even exceeding the cut-off level typically used for the diagnosis of AMI (Eijsvogels et al. [@CR10]; Koller [@CR16]; Neumayr et al. [@CR21]; Shave et al. [@CR26], [@CR25]; Whyte et al. [@CR33]; Wu [@CR34]).

Previous studies indicated that cardiovascular risk factors are associated with higher baseline cTn-levels under resting conditions (Wallace et al. [@CR32]). Interestingly, recent clinical and epidemiological studies have demonstrated that these elevated resting cTn levels are predictive of all-cause mortality (Daniels et al. [@CR5]; de Lemos et al. [@CR7]; Saunders et al. [@CR23]) and future cardiovascular disease (Daniels et al. [@CR5]; Everett et al. [@CR11]; Saunders et al. [@CR23]) in the selected patient groups as well as in the general population. If cTnI levels are higher at baseline, cTnI levels may rise even more under demanding conditions such as exercise. Therefore, subjects with increased cardiovascular risk may demonstrate a larger exercise-induced increase in cTnI compared to healthy controls.

Obesity represents an important and common cardiovascular risk factor (Gelber et al. [@CR13]), whilst the prevalence of obesity is still rising (across all ages) and affecting both the developed and developing world (James [@CR15]). Some previous studies found that measures of obesity, such as body mass index, may be associated with higher resting cTn-levels in the general public (de Lemos et al. [@CR7]; Saunders et al. [@CR23]). However, it is currently unknown whether obesity alters the exercise-induced troponin release. This is of special importance as exercise training is routinely prescribed as an effective strategy to lose weight to individuals with obesity. Therefore, we assessed the effect of obesity on cardiac troponin release after prolonged moderate-intensity exercise. We measured cTnI concentrations in lean, overweight and obese subjects with comparable training status before and immediately after a single bout of prolonged exercise. For this purpose, we examined changes in absolute cTnI-levels, identified those with an elevation in cTnI above the cut-off value for acute myocardial infarction, and examined whether these post-exercise cTnI-levels were related to obesity or to other individual or exercise-related factors. We hypothesize to find higher cTnI levels in obese compared to overweight and lean subjects.

Methods {#Sec2}
=======

Subjects {#Sec3}
--------

Ninety-seven participants were included and stratified for body mass index (BMI), as this measure is frequently used and widely adopted to define overweight/obesity. Subjects were defined as lean (BMI \< 25, *n* = 30), overweight (25 ≤ BMI \< 30, *n* = 29) or obese (BMI ≥ 30 kg/m^2^, *n* = 28) and were allocated to walk 30, 40 or 50 km (Table [1](#Tab1){ref-type="table"}). In addition, we also assessed body fat percentage and waist circumference as alternative markers of overweight/obesity. Written informed consent was obtained from all participants prior to the start of the study. This study was approved by the Medical Ethical Committee of the Radboud University Nijmegen Medical Centre, and was conducted in accordance with the Declaration of Helsinki.Table 1Subject characteristics and details about the health status, presented per subgroupBMI \< 2525 ≤ BMI \< 30BMI ≥ 30*P* valueDemographic characteristics Sex (men:women)15:1515:1425:13-- Age (years)57 ± 1956 ± 1153 ± 90.53 Height (cm)174 ± 11174 ± 9175 ± 90.84 Weight (kg)69.5 ± 11.283.5 ± 8.1^a^101.4 ± 10.7^a,b^\<0.001 Body-mass index (kg/m^2^)22.8 ± 1.927.4 ± 1.4^a^32.9 ± 1.9^a,b^\<0.001 Waist circumference (cm)93 ± 6102 ± 6^a^111 ± 7^a,b^\<0.001 Waist to hip ratio0.91 ± 0.070.95 ± 0.060.99 ± 0.07^a,b^\<0.001 Body fat (%)29 ± 634 ± 6^a^38 ± 6^a,b^\<0.001 Glucose (mmol/L)5.4 ± 1.35.4 ± 0.55.7 ± 1.40.41 Cholesterol (mmol/L)5.3 ± 1.15.4 ± 1.15.5 ± 1.10.85 Triglycerides (mmol/L)1.1 ± 0.61.5 ± 0.6^a^1.5 ± 0.8^a^0.07 High density lipoproteins (mmol/L)1.5 ± 0.31.2 ± 0.2^a^1.2 ± 0.3^a^0.001 Low density lipoproteins (mmol/L)3.3 ± 0.93.6 ± 1.03.6 ± 1.00.54Health status Mean distance trained (km/year)^c^578 ± 651452 ± 715633 ± 5870.54 Mean arterial pressure (mm Hg)98 ± 11104 ± 11107 ± 13^a^0.011 Use of prescribed medicines (%)476282^a^0.010 Diuretics (%)33160.10 Anti-hypertensive drugs (%)1324370.09 Statins (%)1010160.71 Beta-blockers (%)77130.57 Anti-diabetic drugs (%)30110.13 Pathology (%)5372680.26 Hypertension (%)2024370.27 Hypercholesterolemia (%)1310210.45 Skin disease (%)724160.18 Osteoporosis (%)101050.69 Asthma (%)314160.24 Diabetes (%)30110.13^a,\ b^Post-hoc significant difference in relation to lean and overweight subjects respectively^c^Ln-transformation was applied as a non-Gaussian distribution was present

Experimental design {#Sec4}
-------------------

Subjects participated in the International Nijmegen Four Days Marches, an annual walking event in The Netherlands, and walked 30 km (30%), 40 km (47%) or 50 km (23%) at a self selected pace. 12--36 h prior to the start of the march, baseline measurements (subject characteristics, health and training status) were conducted under controlled conditions. 15 min prior to the exercise bout, heart rate and core body temperature were measured. During exercise, heart rate and core body temperature were measured every subsequent 5 km. Immediately after finishing, all measurements were repeated.

Measurements {#Sec5}
------------

### Subject characteristics {#Sec6}

At baseline, body mass (Seca 888 scale, Hamburg, Germany) and height were measured in duplicate and BMI was calculated. A four-point skinfold thickness measurement (biceps, triceps, sub-scapular, supra-iliac) was obtained by a well-trained and highly experienced researcher to calculate the body fat percentage (Durnin and Womersley [@CR9]). Waist circumference was measured midway between the lower rib margin and iliac crest. Hip circumference was measured at the level of widest circumference over the greater trochanters. Waist to-hip ratio was calculated as waist circumference divided by hip circumference. Resting heart rate and blood pressure were measured twice using an automated sphygmomanometer (M5-1 intellisense, Omron Healthcare, Hoofddorp, The Netherlands) after 5-min seated rest. Finally, all subjects completed a questionnaire about their physical activity (hours of sport participation per week), training status (walking-specific training history in the year preceding the walking march) and health status (presence of pathology and use of medication).

### Core body temperature {#Sec7}

Core body temperature was assessed using a portable telemetry system (CorTemp™ system, HQ Inc, Palmetto, USA), which has been demonstrated to be safe and reliable (Byrne and Lim [@CR4]; Gant et al. [@CR12]). Participants ingested an individually calibrated telemetric temperature sensor the evening preceding the experiment. Prior to the start of the exercise, core body temperature of each individual participant was measured using an external recorder. Baseline core body temperature was defined as the average of three consecutive measurements within 30 s. Similarly, core body temperature was measured at every 5 km point during the march. The highest value of these measurements was presented as maximum core body temperature.

### Exercise intensity {#Sec8}

Heart rate was measured with a two-channel ECG chest band system (Polar Electro Oy, Kempele, Finland) simultaneously with core body temperature (i.e. every 5 km point, 3 consecutive measurements which were taken within 30 s), using the same data recorder. Mean heart rate during exercise was calculated as the average heart rate, excluding the values derived directly before the start and after the finish. Exercise intensity was calculated by dividing the mean heart rate during exercise by the maximal predicted heart rate (208--0.7 age) (Tanaka et al. [@CR29]). Subsequently, exercise intensity was presented as a percentage of maximal heart rate (%HR~max~).

### Blood analysis {#Sec9}

Ten ml of venous blood were drawn from an antecubital vein at baseline and directly after finishing. Whole venous blood was collected in serum-gel vacutainer tubes and allowed to clot for \~45 min. After centrifugation, serum was aliquoted, frozen and stored at −80°C for later analysis. Analysis was performed on a single day using the same calibration and set-up to minimize variation. cTnI was analysed using a highly-sensitive cTnI-assay (Centaur TnI-Ultra, Siemens Healthcare Diagnostics, Breda, The Netherlands). The assay imprecision of the highly-sensitive cTnI-assay was 5.3% at 0.08 μg/L and 3.0% at 27.2 μg/L. A cTnI-value of 0.04 μg/L is the clinical cut-off value for myocardial infarction (Apple et al. [@CR1]).

### Ambient conditions {#Sec10}

Throughout the experiment, dry bulb, wet bulb, and globe temperatures were measured every 30 min using a portable climate monitoring device (Davis instruments inc., Hayward, USA) positioned at the start/finish area. The wet bulb globe temperature index (WBGT) was calculated using the formula: WBGT = 0.1 (*T*~dry\ bulb~) + 0.7 (*T*~wet\ bulb~) + 0.2 (*T*~globe~) (Armstrong et al. [@CR2]).

Statistical analysis {#Sec11}
--------------------

All values were presented as mean ± standard deviation, unless indicated otherwise. Statistical analyses were performed using SPSS 16.0 (SPSS, Chicago, IL, USA). The level of statistical significance was set at *P* \< 0.05. The normality of the data distribution was examined by the Kolmogorov--Smirnov test. When data demonstrated a non-Gaussian distribution, Ln-transformation was applied. Comparisons between groups were assessed using a one-way ANOVA for continuously distributed data. A two-way repeated measures ANOVA was applied to examine the change in cTnI after exercise in the three distinct groups (exercise × group). Post hoc *t* tests with the Least Square Difference correction for multiple comparisons were performed when the ANOVA reported a significant main or interaction effect. A backward stepwise linear regression analysis was used to identify factors that significantly relate to post-exercise cTnI-levels. We have included BMI, age, sex, exercise intensity and pre-existing cardiovascular pathology as potential determinants of post-exercise cTnI-levels as previous studies have demonstrated evidence that these factors may relate to exercise-induced cTnI release (Eijsvogels et al. [@CR10]; Shave et al. [@CR27]). In addition, we replaced BMI with two alternative measures of obesity (fat percentage and waist circumference) in the regression analysis to further assess the effect of obesity on post-exercise cTnI levels. Finally, using the same sets of parameters, a binary logistic regression analysis was used to identify factors that contribute to the positive cTnI-samples (cTn \> URL). The odds ratio (OR) and 95% confidence interval (CI) were presented for those factors that were identified as significant factors to contribute to a positive cTnI-sample.

Results {#Sec12}
=======

The three BMI groups were not different in age and height, but as expected differed significantly in weight, BMI, body surface area, waist circumference and body fat percentage (Table [1](#Tab1){ref-type="table"}). Participation in sports activities and the distance trained was not different across groups (Table [1](#Tab1){ref-type="table"}), but the average training distance of 560 km suggested that our subjects were well prepared for the walking march. No differences in the prevalence of (cardiovascular) pathology were found (Table [1](#Tab1){ref-type="table"}). Obese subjects, however, showed a higher mean arterial pressure and used more prescribed medication than their lean counterparts (Table [1](#Tab1){ref-type="table"}).

Exercise characteristics {#Sec13}
------------------------

All subjects successfully completed the exercise bout. The WBGT increased from 14.0°C in the morning to a maximum of 25.0°C in the afternoon. Walking speed did not significantly differ across groups (Table [2](#Tab2){ref-type="table"}). Baseline and maximum core body temperature during exercise were not different between lean, overweight, and obese subjects, whilst also exercise intensity (%HR~max~) was comparable across groups (Table [2](#Tab2){ref-type="table"}).Table 2Exercise characteristics per BMI groupBMI \< 2525 ≤ BMI \< 30BMI ≥ 30*P* valueExercise characteristicsWalking distance0.87 30 (km)343424 40 (km)434552 50 (km)232124 Exercise duration (hh:mm)8:32 ± 1:588:39 ± 1:258:48 ± 1:230.79 Speed (km/h)4.8 ± 0.74.7 ± 0.84.7 ± 0.70.69 Baseline core body temperature (°C)37.5 ± 0.437.6 ± 0.537.5 ± 0.30.55 Maximum core body temperature (°C)38.3 ± 0.338.4 ± 0.338.5 ± 0.30.053 Exercise intensity (% HR~max~)71 ± 971 ± 1074 ± 80.30*P* value refers to a One-Way ANOVA

Cardiac troponin {#Sec14}
----------------

Ln-transformation was applied to the cTnI data set, as a non-Gaussian distribution was found. Baseline cTnI levels were not different across the three groups. The two-way ANOVA revealed a significant increase in cTnI from 0.010 ± 0.006 to 0.024 ± 0.046 μg/L after exercise (*P* \< 0.001) (Fig. [1](#Fig1){ref-type="fig"}). However, the magnitude of the exercise-induced increase in cTnI in lean (pre: 0.009 ± 0.007, post: 0.014 ± 0.010 μg/L) was not different from overweight (pre: 0.012 ± 0.008, post: 0.040 ± 0.085 μg/L) or obese subjects (pre: 0.009 ± 0.005, post: 0.021 ± 0.016 μg/L) (Fig. [1](#Fig1){ref-type="fig"}). To gain further insight into factors that contribute to cTnI-release, a backward linear regression analysis identified age (β = 0.27, *P* = 0.003), sex (β = −0.19, *P* = 0.031) and exercise intensity (%HR~max~, β = 0.47, *P* \< 0.001, Fig. [2](#Fig2){ref-type="fig"}), but not BMI and pre-existing cardiovascular pathology, as significant predictors of post-exercise cTnI-level (*r*^2^ = 0.38, *P* \< 0.001). Using fat percentage as a marker for obesity, we identified the same predictor variables with a comparable total predicted variance (*r*^2^ = 0.36, *P* \< 0.001). Also using waist circumference we found the same total predicted variance (*r*^2^ = 0.38, *P* \< 0.001), and confirmed the predictive capacity of age (β = 0.31, *P* \< 0.001) and exercise intensity (%HR~max~, β = 0.43, *P* \< 0.001). However, waist circumference (β = 0.22, *P* \< 0.01) replaced sex as a significant predictor.Fig. 1Pre- (*black bars*) and post-exercise (*white bars*) cTnI levels in lean (BMI \< 25 kg/m^2^, *n* = 30), overweight (25 ≤ BMI \< 30 kg/m^2^, *n* = 29) and obese subjects (BMI ≥ 30 kg/m^2^, *n* = 38). Two-way RM ANOVA revealed a significant time (*P* \< 0.001) and group (*P* = 0.033) effect. However, no interaction was present (time × group, *P* = 0.27) which indicates that the exercise-induced increase in cTnI was not significantly different across groups. *Error bars* represent SEFig. 2Correlation between exercise intensity (expressed as percentage of maximum predicted heart rate) and Ln-transformed cardiac troponin I levels (cTnI). An increase in exercise intensity is significantly related to higher levels of cTnI (*P* \< 0.001, *r* = 0.48)

Eleven of our participants (9 male, 2 female) showed a cTnI level above the AMI cut-off (cTn \> URL). A Chi-square test revealed that the presence of cTn \> URL differed between lean, overweight and obese subjects (*n* = 0, 7 and 4, respectively, *P* = 0.014). However, subjects with cTnI \< ULR and cTnI \> URL did not differ in age, BMI, fat percentage or waist circumference (corrected for sex) or presence of diseases (i.e. hypertension, hypercholesterolemia and diabetes), whilst exercise intensity was significantly higher in subjects with cTn \> URL (Table [3](#Tab3){ref-type="table"}). Using binary logistic regression analysis, we found that exercise intensity (%HR~max~, *P* \< 0.01, OR = 1.1, CI: 1.0--1.3) was associated with a cTn \> URL. This finding was present, independent of using BMI, fat percentage or waist circumference as a measure of obesity in our model.Table 3Subject characteristics and cardiovascular risk factors in subjects with a cTnI level below (cTn \< URL) and above (cTn \> URL) the clinical cut-off value for AMIcTn \< URLcTn \> URL*P* valueSex (men:women)46:409:20.074Age (yr)55 ± 1454 ± 80.78Body-mass index (kg/m^2^)28.0 ± 4.729.4 ± 3.90.32Fat percentage (%)34 ± 734 ± 60.84Waist circumference (mm)97 ± 13105 ± 110.13Exercise intensity (%)71 ± 980 ± 90.003Use of prescribed medicines (%)67450.15Hypertension (%)29180.45Hypercholesterolemia (%)1700.13Diabetes (%)600.41Smoking (%)7180.21A students *T* Test (continuous parameters) and a Chi Square test (binominal parameters) were used to compare cTn \< URL with cTn \> URL

Discussion {#Sec15}
==========

This is the first study, to our knowledge, to directly examine the impact of obesity on cTnI-release during prolonged exercise. Our results indicate that prolonged moderate-intensity walking exercise significantly elevates cTnI-levels in asymptomatic subjects. More importantly, and in contrast to our hypothesis, the magnitude of the absolute cTnI-increase was comparable between lean, overweight, and obese subjects. When using the cTnI cut-off level for diagnosis of AMI (Thygesen et al. [@CR31]), 11% of our asymptomatic participants demonstrated a positive test. Nonetheless, our statistical analysis revealed that these positive cTnI tests could not be explained through measures of obesity (BMI, body fat percentage or waist circumference).

Analysis of cTnI is recommended as a sensitive and specific marker for cardiac damage in the diagnosis of AMI (Morrow et al. [@CR20]; Thygesen et al. [@CR31]; Wu [@CR34]). The observation that cTnI-levels were elevated after exercise in lean, overweight and obese subjects, with even 11% of our population (*n* = 11) exceeding the cut-off value for AMI, is highly clinically relevant. Whilst previous studies predominantly focused on cTnI-levels in athletes after high-intensity exercise (Dawson et al. [@CR6]; George et al. [@CR14]; Middleton et al. [@CR19]; Scharhag et al. [@CR24]), we showed that prolonged moderate-intensity walking exercise (72% of the maximal predicted heart rate) can lead to significant elevations of post-exercise cTnI in a heterogeneous group of asymptomatic humans.

We found that the exercise-induced increase in cTnI is comparable between lean, overweight, and obese subjects. This suggests that, in contrast to our hypothesis, obesity does not affect the magnitude of post-exercise cTnI elevation. Indeed, linear regression analysis using various measures of obesity (i.e. BMI, fat percentage and waist circumference) identified that exercise intensity, age and sex significantly contribute to the post-exercise cTnI level. Although one of the models replaced sex with waist circumference, this finding may be confounded by the co-linearity between these measures. In addition, 9 of the 11 subjects with cTnI-levels above the clinical cut-off value were men who typically demonstrate a larger waist circumference than women. Furthermore, we demonstrated that BMI, body fat percentage, and waist circumference were not different between subjects with and without a positive cTnI test, whilst the binary logistic regression analysis identified exercise intensity as a predictor of a positive cTnI sample. Taken together, our data suggests that obesity unlikely contributes to the magnitude of the post-exercise elevation in cTnI.

Although obesity may not alter the magnitude of the exercise-induced increase in cTnI, our observation does not necessarily invalidate the hypothesis that subjects with cardiovascular risk may demonstrate a larger exercise-induced increase in cTnI. Indeed, we identified advanced age and male sex, i.e. both well-established cardiovascular risk factors, as independent predictors for the magnitude of the exercise-induced increase in cTnI. Interestingly, a recent multivariable regression analysis identified age and sex, but also fasting glucose and NT-proBNP, as significant predictors for resting cTnT in the general community (Xu et al. [@CR35]). This provides indirect support for the above hypothesis. In addition, since we performed this study, there is evolving evidence that cardiovascular risk factors than obesity (e.g. diabetes mellitus and hypertension) have a more profound effect on resting cTn-levels (deFilippi et al. [@CR8]; Xu et al. [@CR35]). Unfortunately, due to the selection criteria for our study, subgroups with diabetes and/or cardiovascular risk in our study are too small to perform meaningful statistical analysis. We strongly support future studies to examine whether other cardiovascular risk factors than obesity influence the exercise-induced elevation in cTn.

Elevated cTnI levels are suggestive for cardiac damage, but the average cTnI increase in our study was small and was not associated with symptoms of cardiac injury. It may well be possible that the increase in cTnI did not reflect irreversible ischemic myocardial "damage", but relates to a physiological response during prolonged exercise. The elevated heart rate during exercise may cause an increased mechanical stress on the heart, possibly leading to an increased release of cTnI. Interestingly, our study identified exercise intensity as the strongest predictor for the increase of cTnI levels, but also for a positive cTnI test. Exercise intensity, and the associated increased myocardial work, may therefore contribute to cTnI-release during prolonged moderate-intensity exercise. These findings are in agreement with a recent paper that found that exercise intensity influenced the magnitude of the troponin response during marathon running (Legaz-Arrese et al. [@CR18]). Moreover, the increased myocardial work can also transiently accelerate the constant process of apoptosis and regeneration in the myocardium (Beltrami et al. [@CR3]). The very small amounts of cardiac 'damage' are subsequently repaired as part of the normal regenerative capacity of the myocardium, but would also cause a temporal increase in cTnI levels post-exercise. A last explanation relates to an impaired clearance of troponin from the circulation. Blood flow in the abdominal area and kidneys reduces markedly during exercise (Qamar and Read [@CR22]; Suzuki et al. [@CR28]; Thijssen et al. [@CR30]). Consequently, the kidneys capacity to secrete substances is attenuated (Suzuki et al. [@CR28]), possibly resulting in a small increase in cTnI concentration in the blood.

Limitations {#Sec16}
-----------

The strengths of this study are the inclusion of a large group of participants, the unique study design and completion of a prolonged exercise bout. Due to practical limitations, we did not determine maximal heart rate, but used a previously validated and frequently used model to predict maximal heart rate (Tanaka et al. [@CR29]). A limitation is our single post-exercise assessment of cTnI, as previous observations reported a time-dependent change in cTnI after a marathon (Middleton et al. [@CR19]). It is currently unknown whether obesity alters the time-course of cTnI-release after exercise and, therefore, potentially alters our findings. In addition, it must be noted the coefficient of variation increases when measuring at the lower end of the cTnI spectrum. However, excluding subjects with low values (i.e. below 0.006 μg/L) did not alter the major outcomes of our study.

In conclusion, prolonged exercise resulted in a significant increase in cTnI-levels in asymptomatic lean, overweight, and obese subjects. The magnitude of the exercise-induced increase in cTnI was not different among lean, obese, and overweight subjects and relates predominantly to age, gender and exercise intensity. These findings were reinforced by our subjects with a cTnI above the clinical cut-off level, as their BMI, fat percentage and waist circumference was comparable with subjects below this level. Therefore, obesity unlikely contributes to the magnitude of the post-exercise elevation in cTnI.
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